US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

493.22

+10.152.10%

Post-market: 494.000.7800+0.16%19:59 EDT

Volume:1.50M

Turnover:740.33M

Market Cap:53.27B

PE:12.51

High:499.88

Open:485.54

Low:485.00

Close:483.07

Loading ...

Overview Company News Filings

Regeneron Pharmaceuticals Announces Positive Results from Dupixent Trial in Atopic Dermatitis Patients with Skin of Color at RAD Conference

Dupixent® (Dupilumab) Data at Revolutionizing Atopic Dermatitis (Rad) Conference Reinforce Use in Atopic Dermatitis Patients With Skin of Color

THOMSON REUTERS

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Wall Street Shows Love for Kymera Stock After Biotech's Promising Drug Trial -- Barrons.com

BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle

BUZZ-UBS cuts Regeneron PT amid lung disease drug trial setback

UBS Adjusts Regeneron Pharmaceuticals Price Target to $560 From $633, Maintains Neutral Rating

MT Newswires Live

Regeneron Pharma Is Maintained at Neutral by UBS

MAIA Biotechnology Reports Promising Phase 2 Trial Results for Ateganosine in Treating Resistant Non-Small Cell Lung Cancer

23andMe seeks new bids after $305 million offer from its co-founder

Wolfe Research Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $925

MT Newswires Live

RBC Capital Reaffirms Their Hold Rating on Regeneron (REGN)

Bernstein Sticks to Its Buy Rating for Regeneron (REGN)

Regeneron Pharma Is Maintained at Overweight by Morgan Stanley

BUZZ-Kymera rises after positive early-stage results for experimental drug

BRIEF-Regeneron Expands Clinical-Stage Obesity Portfolio

Regeneron Pharmaceuticals Inc : Bernstein Cuts Target Price to $750 From $896

THOMSON REUTERS

Kymera Stock Jumps. New Dermatitis Pill Could Challenge Regeneron Blockbuster. -- Barrons.com

Hansoh Pharmaceutical Signs $80 Million License Agreement with Regeneron for Drug Development

Regeneron Says Libtayo Shows Strong Results in Adjuvant Skin Cancer Trial

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/REGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"REGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","market":"US","secType":"STK","nameCN":"Regeneron Pharmaceuticals","latestPrice":493.22,"timestamp":1749240000000,"preClose":483.07,"halted":0,"volume":1497999,"hourTrading":{"tag":"盘后","latestPrice":494,"preClose":493.22,"latestTime":"19:59 EDT","volume":87785,"amount":43298004.1386,"timestamp":1749254389009},"delay":0,"floatShares":105000000,"shares":108000000,"eps":39.427654,"marketStatus":"Market Closed","change":10.15,"latestTime":"06-06 16:00:00 EDT","open":485.54,"high":499.88,"low":485.0001,"amount":740332017.86604,"amplitude":0.030803,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":39.427654,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":483.07,"dividendRate":0.003568,"preHourTrading":{"tag":"盘前","latestPrice":487.89,"preClose":483.07,"latestTime":"09:28 EDT","volume":854,"amount":415941.9383,"timestamp":1749216521919},"postHourTrading":{"tag":"盘后","latestPrice":494,"preClose":493.22,"latestTime":"19:59 EDT","volume":87785,"amount":43298004.1386,"timestamp":1749254389009},"volumeRatio":0.4973122893402916,"impliedVol":0.425,"impliedVolPercentile":0.772},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"REGN\",,,,,undefined,":{"symbol":"REGN","floatShares":105000000,"roa":"6.91%","roe":"15.96%","lyrEps":40.895273,"volumeRatio":0.4973122893402916,"shares":108000000,"dividePrice":1.76,"high":499.88,"amplitude":0.030803,"preClose":483.07,"low":485.0001,"week52Low":476.4869,"pbRate":"1.81","psRate":"3.78","week52High":1211.2,"institutionHeld":0.8744,"latestPrice":493.22,"eps":39.427654,"divideRate":0.003568,"volume":1497999,"delay":0,"ttmEps":39.427654,"open":485.54,"prevYearClose":712.33,"prevWeekClose":490.28,"prevMonthClose":490.28,"prevQuarterClose":634.23,"fiveDayClose":490.28,"twentyDayClose":547.67,"sixtyDayClose":689.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"REGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541909845","title":"Regeneron Pharmaceuticals Announces Positive Results from Dupixent Trial in Atopic Dermatitis Patients with Skin of Color at RAD Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2541909845","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541909845?lang=en_us&edition=fundamental","pubTime":"2025-06-08 06:30","pubTimestamp":1749335422,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals Announces Positive Results from Dupixent Trial in Atopic Dermatitis Patients with Skin of Color at RAD Conference. Regeneron Pharmaceuticals, Inc.  and Sanofi recently announced results from the DISCOVER Phase 4, single-arm, open-label trial of Dupixent  in adults and adolescents with moderate-to-severe atopic dermatitis with skin of color. The results were presented at the 2025 Revolutionizing Atopic Dermatitis  Conference. This trial marks the first clinical investigation of Dupixent in a large population with darker skin tones. Findings demonstrated significant improvements in disease severity, with 76% of participants achieving a 75% or greater improvement. Notable reductions in hyperpigmentation, dry skin, and itch were also observed. The safety profile was consistent with existing data, and the trial supports a commitment to advancing the understanding of chronic diseases in communities of color.Disclaimer: This news brief was created by Public Technolog","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250607:nNDL2kRFKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU0823434740.USD","LU2210149790.SGD","LU2106854487.HKD","LU0823434583.USD","LU0289739699.SGD","LU2210150020.SGD","LU0889565916.HKD","LU0823416689.USD","LU2089984988.USD","LU0109394709.USD","LU2237438978.USD","REGN","BK4588","IE00BGHQF748.EUR","LU0114720955.EUR","LU0320765992.SGD","NDAQ","BK4112","LU0882574055.USD","BK4139","IE00B3QW5Z07.USD","LU0053666078.USD","IE00B64PRP62.GBP","LU2362541513.USD","IE00BKPKM429.USD","LU2362541273.HKD","LU1917777945.USD","LU0058720904.USD","LU2468319806.SGD","LU2362540622.SGD","BK4585","LU2023250504.SGD","LU1974910355.USD"],"gpt_icon":0},{"id":"2541184590","title":"Dupixent® (Dupilumab) Data at Revolutionizing Atopic Dermatitis (Rad) Conference Reinforce Use in Atopic Dermatitis Patients With Skin of Color","url":"https://stock-news.laohu8.com/highlight/detail?id=2541184590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541184590?lang=en_us&edition=fundamental","pubTime":"2025-06-08 06:30","pubTimestamp":1749335403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250607:nTUA4YDW9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0882574055.USD","LU0114720955.EUR","LU0823434740.USD","LU2362541273.HKD","BK4588","LU2023250504.SGD","LU2468319806.SGD","LU2362540622.SGD","LU0320765992.SGD","REGN","LU0109394709.USD","LU0053666078.USD","LU1917777945.USD","LU0289739699.SGD","LU2089984988.USD","LU2106854487.HKD","BK4585","LU1974910355.USD","LU2237438978.USD","BK4139","LU2362541513.USD","LU0823416689.USD","LU0823434583.USD","LU0058720904.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2541893268","title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2541893268","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541893268?lang=en_us&edition=fundamental","pubTime":"2025-06-07 04:48","pubTimestamp":1749242880,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  rose 2.10% to $493.22 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.03% to 6,000.36 and the Dow Jones Industrial Average  rising 1.05% to 42,762.87.The stock's rise snapped a three-day losing streak.Regeneron Pharmaceuticals Inc. closed 59.28% below its 52-week high of $1,211.20, which the company reached on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Amgen Inc.  rose 1.13% to $290.33, Moderna Inc.  rose 5.13% to $27.46, and Gilead Sciences Inc.  rose 1.81% to $112.46.Trading volume  eclipsed its 50-day average volume of 1.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled June 6, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independentl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2541059920","title":"Wall Street Shows Love for Kymera Stock After Biotech's Promising Drug Trial -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2541059920","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541059920?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:16","pubTimestamp":1749154560,"startTime":"0","endTime":"0","summary":"Shares of the biotech Kymera Therapeutics are up 50% since Monday, when data from an early trial hinted that its pill might relieve dermatitis and asthma comparably to the Regeneron Pharmaceuticals blockbuster injectable Dupixent.Wall Street applauded. Shares of the Boston drug developer got several upgrades to a Buy. A half-a-dozen analysts boosted price targets -- if only to stay ahead of the stock's jump from $30 to $46.Kymera's Phase 1 study compared its pill to a placebo in 118 healthy volunteers. Its pill, KT-621, is one of a new class of drugs called protein-degraders, which can block proteins that act as the on-switches for particular troublemaking genes. That could make them good treatments for cancer and for autoimmune ailments.KT-621 appears to be the first drug to successfully block STAT6, which triggers inflammation in autoimmune disorders like dermatitis. The Phase 1 data showed STAT6 levels dropping near zero. Two biochemical markers of inflammation also fell -- in amoun","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655156.SGD","LU0320765646.SGD","BK4516","LU2023251221.USD","LU0882574055.USD","LU2357305700.SGD","LU0267386448.USD","REGN","LU0106261372.USD","LU0823434583.USD","LU2089984988.USD","LU0225283273.USD","LU1548497426.USD","LU0053666078.USD","LU0889565916.HKD","SNY","BK4585","LU0158827781.USD","BK4007","LU1917777945.USD","KYMR","LU2468319806.SGD","LU2271345857.HKD","LU1989772840.SGD","LU0289739699.SGD","LU0158827948.USD","LU1720051108.HKD","LU2106854487.HKD","LU2133065610.SGD","LU0058720904.USD","LU1162221912.USD","BK4504","IE00BZ1G4Q59.USD","LU1732800096.USD","LU1668664300.SGD","LU0006306889.USD","LU2237438978.USD","LU0823434740.USD","BK4581","LU2028103732.USD","LU0114720955.EUR","LU0971096721.USD","BK4534","BK4127","LU0795875169.SGD","LU2362540622.SGD","LU1732799900.SGD","LU0314104364.USD","LU0098860793.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2541704350","title":"BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle","url":"https://stock-news.laohu8.com/highlight/detail?id=2541704350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541704350?lang=en_us&edition=fundamental","pubTime":"2025-06-06 02:03","pubTimestamp":1749146604,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, CircleEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nL6N3S80F2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMI","REGN","CRCL","IE00BK4W5M84.HKD","LU0077335932.USD","PVH","IE00BLSP4452.SGD","LU2413666426.HKD","SO","COUR","CBRL","LU2362541273.HKD","IE00B7SZLL34.SGD","LU0724618789.USD","TXN","DLTR","LU2237438978.USD","NEM","FCX","LU1235294995.USD","SCCO","BK4563","BPMC","LU2237443895.HKD","RGNX","HL","FIVE","LU0354030438.USD","LU0912757837.SGD","BV","AVGO","CDE","UDMY","FERG","LU0345780521.USD","LU0345780950.USD","LTH","LU0198837287.USD","CBUS","LU0476273544.USD","TRUMP.USD.CC","WEC","CHWY","PHIO","BW","CHPT","TSYW.SI"],"gpt_icon":1},{"id":"2541074870","title":"BUZZ-UBS cuts Regeneron PT amid lung disease drug trial setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2541074870","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541074870?lang=en_us&edition=fundamental","pubTime":"2025-06-05 23:36","pubTimestamp":1749137816,"startTime":"0","endTime":"0","summary":"BUZZ-UBS cuts Regeneron PT amid lung disease drug trial setback** Brokerage UBS cuts PT on drugmaker Regeneron Pharmaceuticals REGN.O to $560 from $633 ** UBS says it has removed smoker's lung drug, itepekimab, from \"current collaboration pipeline given the regulatory uncertainty and potential competitor entries\"** Company and partner Sanofi SASY.PA said last week that their experimental drug, itepekimab, failed in a late-stage trial, testing it for a lung disease commonly called \"smoker's lung\", but met the goal of another trial for the same disease** UBS says REGN will have higher operating expenses in the near-to-mid term due to integrating 23andMe and increased R&D for obesity treatments** However, UBS expects these costs to decrease after 2030 ** \"Eylea franchise weakness remains a key overhang for our near-term REGN thesis\" - UBS** Including session's move, REGN down 31.8% YTD ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nL3N3S8138:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0053666078.USD","LU2089984988.USD","LU2362540622.SGD","LU2362541273.HKD","LU0289739699.SGD","LU2362541513.USD","LU2106854487.HKD","LU2237438978.USD","REGN","LU0889565916.HKD","LU0823434583.USD","BK4588","LU0114720955.EUR","LU0823434740.USD","LU0823416689.USD","LU0058720904.USD","LU1917777945.USD","LU1974910355.USD","LU0109394709.USD","BK4139","LU0882574055.USD","LU2468319806.SGD","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2541079116","title":"UBS Adjusts Regeneron Pharmaceuticals Price Target to $560 From $633, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2541079116","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541079116?lang=en_us&edition=fundamental","pubTime":"2025-06-05 22:39","pubTimestamp":1749134371,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $745.24, according to analysts polled by FactSet.Price: 483.17, Change: -1.76, Percent Change: -0.36","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REGN"],"gpt_icon":0},{"id":"2541075326","title":"Regeneron Pharma Is Maintained at Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2541075326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541075326?lang=en_us&edition=fundamental","pubTime":"2025-06-05 21:32","pubTimestamp":1749130320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 05, 2025 09:32 ET (13:32 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2541020330","title":"MAIA Biotechnology Reports Promising Phase 2 Trial Results for Ateganosine in Treating Resistant Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2541020330","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541020330?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:04","pubTimestamp":1749125057,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology, Inc., a clinical-stage biopharmaceutical company, has announced positive results from its Phase 2 THIO-101 clinical trial. The trial evaluated the efficacy of their lead clinical candidate, ateganosine , in combination with Regeneron's immune checkpoint inhibitor cemiplimab  for patients with advanced non-small cell lung cancer  resistant to prior therapies. The latest data reveals a median overall survival  of 17.8 months for patients receiving at least one dose of ateganosine, significantly outperforming the typical 5 to 6 months OS seen in standard-of-care chemotherapy for similar cases. These findings suggest that ateganosine may considerably impact the NSCLC treatment landscape, with potential for accelerated FDA approval and exclusivity. The treatment has been generally well-tolerated in this heavily pre-treated patient population.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to pro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDLVbGLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4585","LU1917777945.USD","LU2237438978.USD","LU2362541513.USD","REGN","LU0058720904.USD","LU0882574055.USD","LU0053666078.USD","LU0320765992.SGD","LU2362540622.SGD","LU0823416689.USD","BK4139","LU1974910355.USD","BK4588","LU2106854487.HKD","LU2023250504.SGD","LU0823434583.USD","LU2362541273.HKD","LU2089984988.USD","LU0889565916.HKD","LU2468319806.SGD","LU0109394709.USD","LU0114720955.EUR","LU0289739699.SGD","LU0823434740.USD"],"gpt_icon":0},{"id":"2541709249","title":"23andMe seeks new bids after $305 million offer from its co-founder","url":"https://stock-news.laohu8.com/highlight/detail?id=2541709249","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541709249?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:07","pubTimestamp":1749078429,"startTime":"0","endTime":"0","summary":"23andMe seeks new bids after $305 million offer from its co-founder By Dietrich Knauth","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250604:nL2N3S715V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU1917777945.USD","MEHCQ","LU2237438978.USD","LU0114720955.EUR","LU1974910355.USD","BK4139","BK4588","LU2468319806.SGD","LU0058720904.USD","LU2023250504.SGD","LU2089984988.USD","BK4585","LU0053666078.USD","LU0109394709.USD","LU2362541513.USD","LU2106854487.HKD","LU0889565916.HKD","LU2362541273.HKD","LU0320765992.SGD","LU0289739699.SGD","LU0823434583.USD","BK4196","LU0823416689.USD","LU2362540622.SGD","LU0823434740.USD","REGN"],"gpt_icon":0},{"id":"2540502990","title":"Wolfe Research Adjusts Price Target on Regeneron Pharmaceuticals to $800 From $925","url":"https://stock-news.laohu8.com/highlight/detail?id=2540502990","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540502990?lang=en_us&edition=fundamental","pubTime":"2025-06-04 19:04","pubTimestamp":1749035059,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals (REGN) has an average rating of overweight and mean price target of $745.24, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic resea","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["REGN"],"gpt_icon":0},{"id":"2540775621","title":"RBC Capital Reaffirms Their Hold Rating on Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540775621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540775621?lang=en_us&edition=fundamental","pubTime":"2025-06-03 18:56","pubTimestamp":1748948178,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Hold rating on Regeneron (REGN – Research Report) today and set a price target of $662.00. The comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-hold-rating-on-regeneron-regn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-reaffirms-their-hold-rating-on-regeneron-regn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN"],"gpt_icon":0},{"id":"2540921707","title":"Bernstein Sticks to Its Buy Rating for Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540921707","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540921707?lang=en_us&edition=fundamental","pubTime":"2025-06-03 00:25","pubTimestamp":1748881536,"startTime":"0","endTime":"0","summary":"In a report released today, William Pickering from Bernstein maintained a Buy rating on Regeneron (REGN – Research Report), with a price target of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-sticks-to-its-buy-rating-for-regeneron-regn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-sticks-to-its-buy-rating-for-regeneron-regn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REGN"],"gpt_icon":0},{"id":"2540793552","title":"Regeneron Pharma Is Maintained at Overweight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2540793552","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540793552?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:51","pubTimestamp":1748868660,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 02, 2025 08:51 ET (12:51 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN"],"gpt_icon":0},{"id":"2540798799","title":"BUZZ-Kymera rises after positive early-stage results for experimental drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2540798799","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540798799?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:41","pubTimestamp":1748868085,"startTime":"0","endTime":"0","summary":"BUZZ-Kymera rises after positive early-stage results for experimental drug** Shares of drug developer Kymera Therapeutics KYMR.O rise 39.16% to $41.25 premarket** Company says its experimental oral drug showed robust STAT6 degradation in blood and skin in early-stage trial** The drug, KT-621, targets STAT6 — a signaling protein that plays a key role in immune response      ** Company says results exceeded 90% STAT6 degradation target even at single doses as low as 6.25 mg** KT-621 impact on biomarkers of Th2 immune response were in line or superior to Sanofi SASY.PA and Regeneron's REGN.O Dupixent - KYMR** The study finds that KT-621 was as safe as the placebo, with no severe adverse events** Up to last close, Kymera stock down ~26% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nL3N3S50TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU0882574055.USD","REGN","LU2089984988.USD","LU0823434583.USD","LU0053666078.USD","LU0889565916.HKD","BK4585","LU0320765992.SGD","LU1917777945.USD","KYMR","LU2468319806.SGD","LU0109394709.USD","LU0289739699.SGD","BK4588","LU1974910355.USD","LU2362541513.USD","LU2106854487.HKD","LU0058720904.USD","LU0823416689.USD","LU2237438978.USD","LU0823434740.USD","LU2362541273.HKD","LU0114720955.EUR","LU2362540622.SGD","BK4139"],"gpt_icon":0},{"id":"2540798322","title":"BRIEF-Regeneron Expands Clinical-Stage Obesity Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2540798322","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540798322?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:16","pubTimestamp":1748866563,"startTime":"0","endTime":"0","summary":"BRIEF-Regeneron Expands Clinical-Stage Obesity Portfolio June 2 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:REGENERON EXPANDS CLINICAL-STAGE OBESITY PORTFOLIO WITH STRATEGIC IN-LICENSING OF NOVEL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S30AW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU0053666078.USD","BK4139","LU0320765992.SGD","LU1974910355.USD","LU1917777945.USD","LU2362540622.SGD","LU0289739699.SGD","LU0823434583.USD","LU0889565916.HKD","LU0114720955.EUR","LU0823416689.USD","LU0109394709.USD","LU0058720904.USD","BK4588","LU0823434740.USD","BK4585","LU2023250504.SGD","LU2106854487.HKD","LU2089984988.USD","LU2468319806.SGD","LU0882574055.USD","LU2362541273.HKD","LU2237438978.USD","LU2362541513.USD"],"gpt_icon":0},{"id":"2540616760","title":"Regeneron Pharmaceuticals Inc : Bernstein Cuts Target Price to $750 From $896","url":"https://stock-news.laohu8.com/highlight/detail?id=2540616760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540616760?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:47","pubTimestamp":1748864877,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S50JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","LU0882574055.USD","LU2237438978.USD","LU2468319806.SGD","LU0058720904.USD","LU0289739699.SGD","LU0053666078.USD","LU2106854487.HKD","LU2362541513.USD","BK4585","BK4139","LU2089984988.USD","LU2023250504.SGD","LU0823434740.USD","LU2362541273.HKD","REGN","LU2362540622.SGD","LU0823434583.USD","BK4588","LU0889565916.HKD","LU1917777945.USD","LU0114720955.EUR","LU1974910355.USD","LU0823416689.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2540760340","title":"Kymera Stock Jumps. New Dermatitis Pill Could Challenge Regeneron Blockbuster. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760340?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:44","pubTimestamp":1748864640,"startTime":"0","endTime":"0","summary":"Biotech firm Kymera Therapeutics announced strong results Monday, in the first human tests of a pill for autoimmune ailments like dermatitis and asthma. Its drug seems about a year ahead of other firms developing pills in the hot class of drugs called \"protein degraders\", which can block the on-switch for troublesome genes.The Phase 1 trial for the code-named KT-621 was mainly a safety study, which found that the drug was as benign as a placebo in terms of side effects. But other measures hinted that KT-621 may prove as effective as the big-selling injectable Dupixent from Regeneron and Sanofi, while potentially safer than popular pills like AbbVie's Rinvoq.Concerns about injections and safety have limited the use of immune treatments to a small percentage of those suffering dermatitis. So Schmidt guesses a pill with Dupixent-like effectiveness, and no safety worries, could win at least 10% of annual sales in dermatitis by 2030 -- or about $3 billion.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","LU2552382215.SGD","ABBV","LU0203202063.USD","LU1983299246.USD","LU1988902786.USD","SG9999011175.SGD","LU0795875169.SGD","LU2237443622.USD","SG9999001176.SGD","LU1093756325.SGD","LU2468319806.SGD","REGN","LU0109394709.USD","LU0385154629.USD","LU2063271972.USD","LU0211328371.USD","LU1868836757.USD","LU0106261372.USD","IE0009355771.USD","LU0820561909.HKD","LU0320765646.SGD","LU0949170772.SGD","IE00BJLML261.HKD","LU2750360997.AUD","SGXZ31699556.SGD","LU2361044949.HKD","LU0553294199.USD","LU0965508806.USD","LU1232071149.USD","LU1244550494.USD","IE00BVYPNW00.USD","BK4585","LU1974910355.USD","LU1989772840.SGD","LU0795875086.SGD","IE00B2B36J28.USD","LU0672654240.SGD","LU1366192091.USD","LU0079474960.USD","LU2237438978.USD","LU1732800096.USD","LU2361044865.SGD","LLY","LU0965509010.AUD","SG9999015952.SGD","LU0238689110.USD","LU2362541513.USD","SNY","KYMR"],"gpt_icon":0},{"id":"2540674367","title":"Hansoh Pharmaceutical Signs $80 Million License Agreement with Regeneron for Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2540674367","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540674367?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:24","pubTimestamp":1748863469,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical Group Company Limited has announced a significant licensing agreement with Regeneron Pharmaceuticals, Inc. The agreement grants Regeneron an exclusive worldwide license, excluding the Chinese Mainland, Hong Kong, and Macau, to develop, manufacture, and commercialize HS-20094, an investigational dual GLP-1/GIP receptor agonist. The licensure will see Hansoh receiving an upfront payment of $80 million, with the potential for up to $1.93 billion in milestone payments tied to the product's development, regulatory approval, and commercialization. Additionally, Hansoh will earn double-digit royalties from potential future product sales. HS-20094 has completed multiple Phase II trials with positive results and is currently undergoing a Phase III clinical trial in China. This collaboration marks a strategic advancement for both companies in the biotechnology sector.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. Wh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDL8DrjnQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","LU2089984988.USD","BK1583","LU0114720955.EUR","LU0053666078.USD","LU2023250504.SGD","BK4588","LU2468319806.SGD","LU0823434740.USD","BK1191","LU0320765992.SGD","LU2362541513.USD","03692","LU2106854487.HKD","LU0109394709.USD","LU0058720904.USD","BK4585","LU1917777945.USD","BK4139","LU0823434583.USD","BK1589","LU2362540622.SGD","LU0882574055.USD","LU0289739699.SGD","LU2237438978.USD","REGN","LU0823416689.USD","LU0889565916.HKD","LU2362541273.HKD"],"gpt_icon":0},{"id":"2540576714","title":"Regeneron Says Libtayo Shows Strong Results in Adjuvant Skin Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2540576714","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540576714?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:21","pubTimestamp":1748863276,"startTime":"0","endTime":"0","summary":"Regeneron  said Saturday that Libtayo reduced the risk of recurrence or death by 68% in post-surgical high-risk cutaneous squamous cell carcinoma, meeting the phase 3 C-POST trial's primary endpoint.The immunotherapy also cut the risk of locoregional and distant recurrence by 80% and 65%, respectively, the company said.Median disease-free survival was not reached in the Libtayo group versus 49 months for placebo, with two-year disease-free survival rates of 87% and 64%, respectively, Regeneron said.The company said adverse events of grade 3 or higher occurred in 24% of Libtayo patients versus 14% for placebo, treatment discontinuation due to adverse events was 10% in the Libtayo arm.Regulatory applications for adjuvant use of Libtayo have been submitted in the US and EU, Regeneron added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","LU2023250504.SGD","LU0823416689.USD","REGN","LU2106854487.HKD","LU1974910355.USD","BK4588","LU2468319806.SGD","LU0823434740.USD","LU0320765992.SGD","LU1917777945.USD","LU2089984988.USD","BK4139","LU2362541513.USD","LU0114720955.EUR","LU0882574055.USD","LU0058720904.USD","LU0109394709.USD","LU2362540622.SGD","BK4585","LU2237438978.USD","LU0289739699.SGD","LU0053666078.USD","LU2362541273.HKD","LU0823434583.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/REGN\",params:#limit:5,,,undefined,":[{"date":"2025-05-20","symbol":"REGN","amount":0.88,"announcedDate":"2025-04-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-20","defaultRemindTime":1747747800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-06","payableDate":"2025-05-20","currency":"USD","dateTimestamp":1747713600000,"payDate":"2025-06-06"},{"market":"US","date":"2025-04-29","symbol":"REGN","fiscalQuarterEnding":"2025/03","expectedEps":6.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"pre","actualEps":6.43},{"date":"2025-02-20","symbol":"REGN","amount":0.88,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-20","defaultRemindTime":1740061800000,"name":"再生元制药公司","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-20","payableDate":"2025-02-20","currency":"USD","dateTimestamp":1740027600000,"payDate":"2025-03-20"},{"market":"US","date":"2025-02-04","symbol":"REGN","fiscalQuarterEnding":"2024/12","expectedEps":9.62,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738645200000,"reportTimeType":"pre","actualEps":9.9},{"market":"US","date":"2024-10-31","symbol":"REGN","fiscalQuarterEnding":"2024/09","expectedEps":10.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":11.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"REGN\",market:\"US\",,,undefined,":[{"executeDate":"2025-02-20","recordDate":"2025-02-20","paymentDate":"2025-03-20","value":0.88,"currency":"USD"},{"executeDate":"2025-05-20","recordDate":"2025-05-20","paymentDate":"2025-06-06","value":0.88,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"REGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3214,"buy":0.3929,"hold":0.25,"sell":0.0357,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3929,"analysts":28,"updateTime":1748664000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/REGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"REGN","date":"2025-06-06","current":11.344838,"percent":0.209756,"low":7.447139,"twenty":11.205526,"median":16.611067,"eighty":22.386399,"high":30.763504,"avg":17.241041,"sd":6.056763,"marketCap":51043831635},"quantilePoints":[{"date":"2020-06-12","current":26.215582,"twenty":19.849021,"median":51.102486,"eighty":112.289501,"marketCap":59753175659},{"date":"2020-06-19","current":28.689708,"twenty":19.849021,"median":50.420041,"eighty":111.71033,"marketCap":65392452064},{"date":"2020-06-26","current":27.239005,"twenty":19.849021,"median":49.850558,"eighty":110.92935,"marketCap":62085863918},{"date":"2020-07-02","current":27.733117,"twenty":19.849021,"median":40.392331,"eighty":110.784746,"marketCap":63212094340},{"date":"2020-07-10","current":27.662275,"twenty":19.849021,"median":31.979399,"eighty":110.206964,"marketCap":63050623973},{"date":"2020-07-17","current":28.695946,"twenty":19.849021,"median":31.36985,"eighty":108.726161,"marketCap":65406669581},{"date":"2020-07-24","current":27.131182,"twenty":19.849021,"median":31.004812,"eighty":106.696094,"marketCap":61840103988},{"date":"2020-07-31","current":28.161734,"twenty":19.849021,"median":30.808341,"eighty":104.408478,"marketCap":64189040838},{"date":"2020-08-07","current":21.875339,"twenty":19.849021,"median":30.656632,"eighty":101.923911,"marketCap":65265075387},{"date":"2020-08-14","current":21.60587,"twenty":19.849021,"median":30.354205,"eighty":101.37008,"marketCap":64461113542},{"date":"2020-08-21","current":21.356152,"twenty":19.849021,"median":30.042238,"eighty":99.974583,"marketCap":63716080837},{"date":"2020-08-28","current":21.254572,"twenty":19.849021,"median":29.867177,"eighty":98.620251,"marketCap":63413016686},{"date":"2020-09-04","current":20.469796,"twenty":19.849021,"median":29.681793,"eighty":97.739726,"marketCap":61071635658},{"date":"2020-09-11","current":19.2138,"twenty":19.673575,"median":29.474412,"eighty":97.336675,"marketCap":57324373708},{"date":"2020-09-18","current":19.583792,"twenty":19.656234,"median":29.203553,"eighty":96.645594,"marketCap":58428242785},{"date":"2020-09-25","current":20.247589,"twenty":19.637789,"median":29.093505,"eighty":95.995591,"marketCap":60408682828},{"date":"2020-10-02","current":19.920981,"twenty":19.637789,"median":28.953278,"eighty":94.856997,"marketCap":59434247398},{"date":"2020-10-09","current":21.235526,"twenty":19.637789,"median":28.860353,"eighty":93.407176,"marketCap":63356192158},{"date":"2020-10-16","current":21.153345,"twenty":19.637789,"median":28.756642,"eighty":89.782622,"marketCap":63111004841},{"date":"2020-10-23","current":20.450397,"twenty":19.637789,"median":28.691316,"eighty":88.348748,"marketCap":61013758824},{"date":"2020-10-30","current":19.171828,"twenty":19.596771,"median":28.536662,"eighty":84.18776,"marketCap":57199149284},{"date":"2020-11-06","current":19.330759,"twenty":19.563112,"median":28.419067,"eighty":80.669454,"marketCap":61007874618},{"date":"2020-11-13","current":18.942826,"twenty":19.391778,"median":28.342989,"eighty":76.671574,"marketCap":59783558673},{"date":"2020-11-20","current":17.347954,"twenty":19.273386,"median":28.194062,"eighty":74.98798,"marketCap":54750142517},{"date":"2020-11-27","current":17.191109,"twenty":19.172764,"median":28.166858,"eighty":74.433116,"marketCap":54255138915},{"date":"2020-12-04","current":16.468751,"twenty":19.105699,"median":28.124531,"eighty":73.576979,"marketCap":51975378191},{"date":"2020-12-11","current":16.0447,"twenty":19.031974,"median":28.045787,"eighty":73.249222,"marketCap":50637074210},{"date":"2020-12-18","current":16.684121,"twenty":18.978847,"median":28.003825,"eighty":72.725467,"marketCap":52655084629},{"date":"2020-12-24","current":16.351033,"twenty":18.951722,"median":27.893932,"eighty":72.508831,"marketCap":51603861628},{"date":"2020-12-31","current":16.156398,"twenty":18.869944,"median":27.783005,"eighty":72.122981,"marketCap":50989592766},{"date":"2021-01-08","current":16.67877,"twenty":18.812345,"median":27.748475,"eighty":71.867927,"marketCap":52638197512},{"date":"2021-01-15","current":17.320865,"twenty":18.741004,"median":27.670408,"eighty":71.690256,"marketCap":54664651490},{"date":"2021-01-22","current":17.984699,"twenty":18.702345,"median":27.64431,"eighty":71.398793,"marketCap":56759709378},{"date":"2021-01-29","current":16.849661,"twenty":18.613885,"median":27.588588,"eighty":71.196483,"marketCap":53177529795},{"date":"2021-02-05","current":14.990488,"twenty":18.469712,"median":27.52903,"eighty":70.956334,"marketCap":52664583632},{"date":"2021-02-12","current":14.395598,"twenty":18.339492,"median":27.404838,"eighty":70.822506,"marketCap":50574613240},{"date":"2021-02-19","current":13.94353,"twenty":18.247865,"median":27.322464,"eighty":70.650351,"marketCap":48986410835},{"date":"2021-02-26","current":13.356584,"twenty":18.183087,"median":27.239458,"eighty":70.34583,"marketCap":46924351319},{"date":"2021-03-05","current":13.682665,"twenty":18.137069,"median":27.131182,"eighty":70.094632,"marketCap":48069939939},{"date":"2021-03-12","current":13.975842,"twenty":18.094122,"median":27.034693,"eighty":69.991059,"marketCap":49099928253},{"date":"2021-03-19","current":14.042244,"twenty":17.992123,"median":26.957419,"eighty":69.774786,"marketCap":49333211754},{"date":"2021-03-26","current":14.1374,"twenty":17.91755,"median":26.838925,"eighty":69.560413,"marketCap":49667515342},{"date":"2021-04-01","current":14.078706,"twenty":17.836459,"median":26.740955,"eighty":69.380807,"marketCap":49461309390},{"date":"2021-04-09","current":14.08582,"twenty":17.582883,"median":26.667813,"eighty":69.047731,"marketCap":49486304051},{"date":"2021-04-16","current":14.898948,"twenty":17.531653,"median":26.603923,"eighty":68.92796,"marketCap":52342985492},{"date":"2021-04-23","current":14.400461,"twenty":17.378502,"median":26.576788,"eighty":68.754213,"marketCap":50591699595},{"date":"2021-04-30","current":14.184148,"twenty":17.314319,"median":26.47571,"eighty":68.667059,"marketCap":49831747330},{"date":"2021-05-07","current":12.848195,"twenty":17.236982,"median":26.416524,"eighty":68.548435,"marketCap":51441604940},{"date":"2021-05-14","current":13.362123,"twenty":17.131868,"median":26.350888,"eighty":68.476599,"marketCap":53499269138},{"date":"2021-05-21","current":13.106065,"twenty":16.947039,"median":26.270161,"eighty":68.395732,"marketCap":52474061510},{"date":"2021-05-28","current":12.995106,"twenty":16.837354,"median":26.029338,"eighty":68.15674,"marketCap":52029804872},{"date":"2021-06-04","current":13.239784,"twenty":16.702149,"median":25.825146,"eighty":68.017841,"marketCap":53009447716},{"date":"2021-06-11","current":13.593093,"twenty":16.634935,"median":25.762014,"eighty":67.890019,"marketCap":54424027129},{"date":"2021-06-18","current":13.913037,"twenty":16.514074,"median":25.58899,"eighty":67.722101,"marketCap":55705018881},{"date":"2021-06-25","current":14.239706,"twenty":16.438175,"median":25.425582,"eighty":67.525077,"marketCap":57012935279},{"date":"2021-07-02","current":15.095563,"twenty":16.378422,"median":25.38134,"eighty":67.387984,"marketCap":60439614106},{"date":"2021-07-09","current":15.011762,"twenty":16.299089,"median":25.245133,"eighty":67.28571,"marketCap":60104091610},{"date":"2021-07-16","current":15.085217,"twenty":16.168829,"median":25.161304,"eighty":66.948314,"marketCap":60398191576},{"date":"2021-07-23","current":15.165656,"twenty":16.140773,"median":25.057563,"eighty":66.699512,"marketCap":60720251750},{"date":"2021-07-30","current":14.862006,"twenty":16.05773,"median":24.844212,"eighty":66.473671,"marketCap":59504500482},{"date":"2021-08-06","current":10.234607,"twenty":15.941934,"median":24.580228,"eighty":66.222266,"marketCap":63509831394},{"date":"2021-08-13","current":10.467996,"twenty":15.811105,"median":24.409963,"eighty":65.572203,"marketCap":64958104241},{"date":"2021-08-20","current":11.112707,"twenty":15.71172,"median":24.133895,"eighty":65.35903,"marketCap":68958789033},{"date":"2021-08-27","current":11.113042,"twenty":15.594292,"median":23.952572,"eighty":64.943681,"marketCap":68960868391},{"date":"2021-09-03","current":11.385804,"twenty":15.416611,"median":23.896291,"eighty":64.163045,"marketCap":70653465803},{"date":"2021-09-10","current":10.898585,"twenty":15.358543,"median":23.822687,"eighty":64.001642,"marketCap":67630079271},{"date":"2021-09-17","current":10.921874,"twenty":15.31188,"median":23.556993,"eighty":63.614678,"marketCap":67774594652},{"date":"2021-09-24","current":10.704401,"twenty":15.216063,"median":23.36376,"eighty":63.039237,"marketCap":66425091310},{"date":"2021-10-01","current":9.563257,"twenty":15.168295,"median":23.248274,"eighty":62.60394,"marketCap":59343837641},{"date":"2021-10-08","current":9.215268,"twenty":15.152615,"median":23.044477,"eighty":62.187301,"marketCap":57184424358},{"date":"2021-10-15","current":9.269217,"twenty":15.096804,"median":22.886718,"eighty":61.909902,"marketCap":57519200996},{"date":"2021-10-22","current":9.589562,"twenty":15.075632,"median":22.781044,"eighty":60.689685,"marketCap":59507067244},{"date":"2021-10-29","current":10.721826,"twenty":15.02843,"median":22.711601,"eighty":58.441572,"marketCap":66533217926},{"date":"2021-11-05","current":9.140146,"twenty":15.010362,"median":22.587367,"eighty":56.983625,"marketCap":63939894320},{"date":"2021-11-12","current":9.433987,"twenty":14.972274,"median":22.403299,"eighty":52.676989,"marketCap":65995456216},{"date":"2021-11-19","current":9.75503,"twenty":14.914028,"median":22.242861,"eighty":51.731325,"marketCap":68241309194},{"date":"2021-11-26","current":9.615582,"twenty":14.873644,"median":22.206358,"eighty":51.46717,"marketCap":67265806015},{"date":"2021-12-03","current":9.493174,"twenty":14.846146,"median":22.027357,"eighty":51.289641,"marketCap":66409496151},{"date":"2021-12-10","current":10.006722,"twenty":14.763396,"median":21.89368,"eighty":50.996878,"marketCap":70002024471},{"date":"2021-12-17","current":9.255829,"twenty":14.645835,"median":21.852902,"eighty":50.192382,"marketCap":64749154191},{"date":"2021-12-23","current":9.347001,"twenty":14.543935,"median":21.806579,"eighty":49.835452,"marketCap":65386942979},{"date":"2021-12-31","current":9.43877,"twenty":14.480705,"median":21.69052,"eighty":32.798336,"marketCap":66028913989},{"date":"2022-01-07","current":9.023417,"twenty":14.400343,"median":21.58144,"eighty":31.955254,"marketCap":63123315560},{"date":"2022-01-14","current":9.195447,"twenty":14.360499,"median":21.468059,"eighty":31.332217,"marketCap":64326749814},{"date":"2022-01-21","current":9.287515,"twenty":14.29746,"median":21.412668,"eighty":31.053495,"marketCap":64970811934},{"date":"2022-01-28","current":9.340125,"twenty":14.271924,"median":21.249665,"eighty":30.821672,"marketCap":65338847431},{"date":"2022-02-04","current":8.06582,"twenty":14.211698,"median":21.155814,"eighty":30.665092,"marketCap":65133918575},{"date":"2022-02-11","current":8.414784,"twenty":14.141195,"median":20.886786,"eighty":30.397746,"marketCap":67951902021},{"date":"2022-02-18","current":8.107934,"twenty":14.100469,"median":20.718789,"eighty":30.063963,"marketCap":65473995536},{"date":"2022-02-25","current":8.154462,"twenty":14.0749,"median":20.630748,"eighty":29.944922,"marketCap":65849726202},{"date":"2022-03-04","current":8.177528,"twenty":14.052898,"median":20.548589,"eighty":29.711783,"marketCap":66035994945},{"date":"2022-03-11","current":8.469748,"twenty":13.990355,"median":20.497058,"eighty":29.510771,"marketCap":68395753827},{"date":"2022-03-18","current":9.041269,"twenty":13.952186,"median":20.431603,"eighty":29.231348,"marketCap":73010961095},{"date":"2022-03-25","current":8.96337,"twenty":13.923409,"median":20.297711,"eighty":29.102336,"marketCap":72381904938},{"date":"2022-04-01","current":9.158447,"twenty":13.87369,"median":20.180575,"eighty":28.966736,"marketCap":73957206312},{"date":"2022-04-08","current":9.738536,"twenty":13.848877,"median":20.056598,"eighty":28.871934,"marketCap":78641599112},{"date":"2022-04-14","current":9.661823,"twenty":13.817339,"median":19.925312,"eighty":28.815517,"marketCap":78022122491},{"date":"2022-04-22","current":9.180836,"twenty":13.785109,"median":19.790673,"eighty":28.696957,"marketCap":74138001167},{"date":"2022-04-29","current":8.794298,"twenty":13.737566,"median":19.660289,"eighty":28.556678,"marketCap":71016593927},{"date":"2022-05-06","current":8.46164,"twenty":13.72215,"median":19.591904,"eighty":28.472288,"marketCap":67131266171},{"date":"2022-05-13","current":8.766805,"twenty":13.695689,"median":19.451906,"eighty":28.362701,"marketCap":69552323150},{"date":"2022-05-20","current":8.97894,"twenty":13.651777,"median":19.315239,"eighty":28.201625,"marketCap":71235318701},{"date":"2022-05-27","current":9.408914,"twenty":13.61647,"median":19.182482,"eighty":28.169777,"marketCap":74646563203},{"date":"2022-06-03","current":8.560781,"twenty":13.580763,"median":19.147609,"eighty":28.138912,"marketCap":67917813387},{"date":"2022-06-10","current":7.76575,"twenty":13.496152,"median":19.040029,"eighty":28.05351,"marketCap":61610351191},{"date":"2022-06-17","current":7.88988,"twenty":13.458929,"median":18.983291,"eighty":28.012848,"marketCap":62595151404},{"date":"2022-06-24","current":8.318225,"twenty":13.394252,"median":18.968689,"eighty":27.917096,"marketCap":65993466363},{"date":"2022-07-01","current":8.086125,"twenty":13.329334,"median":18.871653,"eighty":27.782289,"marketCap":64152083907},{"date":"2022-07-08","current":8.44154,"twenty":13.241565,"median":18.818752,"eighty":27.753004,"marketCap":66971801804},{"date":"2022-07-15","current":8.250999,"twenty":13.112583,"median":18.780003,"eighty":27.691117,"marketCap":65460122702},{"date":"2022-07-22","current":7.959958,"twenty":13.007521,"median":18.702505,"eighty":27.643858,"marketCap":63151121765},{"date":"2022-07-29","current":7.89993,"twenty":12.891389,"median":18.620106,"eighty":27.587706,"marketCap":62674883587},{"date":"2022-08-05","current":11.535488,"twenty":11.550716,"median":18.471047,"eighty":27.528467,"marketCap":65600015462},{"date":"2022-08-12","current":11.819359,"twenty":11.550716,"median":18.341073,"eighty":27.404209,"marketCap":67214331124},{"date":"2022-08-19","current":11.624785,"twenty":11.550716,"median":18.231129,"eighty":27.303428,"marketCap":66107829991},{"date":"2022-08-26","current":11.207815,"twenty":11.371909,"median":18.181433,"eighty":27.225906,"marketCap":63736603409},{"date":"2022-09-02","current":10.915297,"twenty":11.30967,"median":18.134856,"eighty":27.121826,"marketCap":62073109919},{"date":"2022-09-09","current":13.616768,"twenty":11.259308,"median":18.095368,"eighty":27.037827,"marketCap":77435835791},{"date":"2022-09-16","current":13.353201,"twenty":11.259308,"median":17.997073,"eighty":26.966349,"marketCap":75936981116},{"date":"2022-09-23","current":13.109373,"twenty":11.259308,"median":17.919992,"eighty":26.835951,"marketCap":74550380180},{"date":"2022-09-30","current":12.95033,"twenty":11.259308,"median":17.763862,"eighty":26.722775,"marketCap":73645935776},{"date":"2022-10-07","current":13.580109,"twenty":11.259308,"median":17.582147,"eighty":26.649626,"marketCap":77227364563},{"date":"2022-10-14","current":13.837473,"twenty":11.259308,"median":17.514489,"eighty":26.601993,"marketCap":78690939491},{"date":"2022-10-21","current":13.421066,"twenty":11.259308,"median":17.357987,"eighty":26.567778,"marketCap":76322920159},{"date":"2022-10-28","current":14.113824,"twenty":11.259308,"median":17.305502,"eighty":26.472046,"marketCap":80262491824},{"date":"2022-11-04","current":14.720939,"twenty":11.259308,"median":17.230044,"eighty":26.401701,"marketCap":79055860306},{"date":"2022-11-11","current":14.606387,"twenty":11.259308,"median":17.119207,"eighty":26.346411,"marketCap":78440681160},{"date":"2022-11-18","current":14.651731,"twenty":11.259308,"median":16.930926,"eighty":26.239227,"marketCap":78684189572},{"date":"2022-11-25","current":14.641787,"twenty":11.259308,"median":16.849661,"eighty":26.033735,"marketCap":78630788605},{"date":"2022-12-02","current":15.241595,"twenty":11.259308,"median":16.684121,"eighty":25.823128,"marketCap":81851934964},{"date":"2022-12-09","current":14.916831,"twenty":11.259308,"median":16.625596,"eighty":25.738839,"marketCap":80107859366},{"date":"2022-12-16","current":14.382056,"twenty":11.259308,"median":16.468751,"eighty":25.567197,"marketCap":77235955333},{"date":"2022-12-23","current":14.453054,"twenty":11.259308,"median":16.426279,"eighty":25.414911,"marketCap":77617238241},{"date":"2022-12-30","current":14.348645,"twenty":11.259308,"median":16.386349,"eighty":25.384384,"marketCap":77056528083},{"date":"2023-01-06","current":14.660083,"twenty":11.259308,"median":16.317075,"eighty":25.250581,"marketCap":78729046385},{"date":"2023-01-13","current":14.361373,"twenty":11.259308,"median":16.169536,"eighty":25.174538,"marketCap":77124881321},{"date":"2023-01-20","current":14.358788,"twenty":11.259308,"median":16.151382,"eighty":25.098264,"marketCap":77110997070},{"date":"2023-01-27","current":14.773045,"twenty":11.259308,"median":16.092523,"eighty":24.875579,"marketCap":79335681376},{"date":"2023-02-03","current":19.278951,"twenty":11.259308,"median":15.99554,"eighty":24.688912,"marketCap":83639799356},{"date":"2023-02-10","current":18.637362,"twenty":11.259308,"median":15.99554,"eighty":24.479131,"marketCap":80856330298},{"date":"2023-02-17","current":18.419158,"twenty":11.259308,"median":15.99554,"eighty":24.334872,"marketCap":79909674829},{"date":"2023-02-24","current":18.62211,"twenty":11.259308,"median":15.99554,"eighty":24.08253,"marketCap":80790160468},{"date":"2023-03-03","current":19.17094,"twenty":11.259308,"median":15.99554,"eighty":23.912342,"marketCap":83171207087},{"date":"2023-03-10","current":18.376354,"twenty":11.259308,"median":15.99554,"eighty":23.83133,"marketCap":79723972404},{"date":"2023-03-17","current":18.392344,"twenty":11.259308,"median":15.99554,"eighty":23.634714,"marketCap":79793343999},{"date":"2023-03-24","current":20.172169,"twenty":11.259308,"median":15.99554,"eighty":23.395584,"marketCap":87514936240},{"date":"2023-03-31","current":20.213251,"twenty":11.270868,"median":16.006911,"eighty":23.269698,"marketCap":87693167878},{"date":"2023-04-06","current":20.300582,"twenty":11.270868,"median":16.006911,"eighty":23.16464,"marketCap":88072043517},{"date":"2023-04-14","current":20.426781,"twenty":11.259308,"median":15.99554,"eighty":22.981137,"marketCap":88619545496},{"date":"2023-04-21","current":19.633424,"twenty":11.259308,"median":15.99554,"eighty":22.826311,"marketCap":85177647089},{"date":"2023-04-28","current":19.560756,"twenty":11.259308,"median":15.99554,"eighty":22.744778,"marketCap":84862383141},{"date":"2023-05-05","current":19.3053,"twenty":11.259308,"median":15.99554,"eighty":22.693077,"marketCap":80748278285},{"date":"2023-05-12","current":19.092498,"twenty":11.247747,"median":15.988674,"eighty":22.679792,"marketCap":79858192074},{"date":"2023-05-19","current":19.141409,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":80062772659},{"date":"2023-05-26","current":18.565743,"twenty":11.247747,"median":15.988674,"eighty":22.52179,"marketCap":77654934150},{"date":"2023-06-02","current":18.723744,"twenty":11.247747,"median":15.988674,"eighty":22.416292,"marketCap":78315804417},{"date":"2023-06-09","current":19.209014,"twenty":11.247747,"median":15.988674,"eighty":22.202364,"marketCap":80345543730},{"date":"2023-06-16","current":20.052795,"twenty":11.247747,"median":15.988674,"eighty":21.930123,"marketCap":83874826599},{"date":"2023-06-23","current":19.969313,"twenty":11.236187,"median":15.981807,"eighty":21.872257,"marketCap":83525647171},{"date":"2023-06-30","current":18.141164,"twenty":11.224626,"median":15.96462,"eighty":21.812599,"marketCap":75879046138},{"date":"2023-07-07","current":18.049231,"twenty":11.224626,"median":15.96462,"eighty":21.69052,"marketCap":75494520326},{"date":"2023-07-14","current":18.462799,"twenty":11.224626,"median":15.96462,"eighty":21.546615,"marketCap":77224350928},{"date":"2023-07-21","current":18.51504,"twenty":11.224626,"median":15.96462,"eighty":21.443977,"marketCap":77442855847},{"date":"2023-07-28","current":19.069195,"twenty":11.224626,"median":15.96462,"eighty":21.26942,"marketCap":79760721743},{"date":"2023-08-04","current":19.014155,"twenty":11.224626,"median":15.96462,"eighty":21.191438,"marketCap":81741853001},{"date":"2023-08-11","current":19.545551,"twenty":11.224626,"median":15.96462,"eighty":20.904333,"marketCap":84026322961},{"date":"2023-08-18","current":19.637239,"twenty":11.224626,"median":15.96462,"eighty":20.742089,"marketCap":84420489392},{"date":"2023-08-25","current":20.487077,"twenty":11.224626,"median":15.96462,"eighty":20.708932,"marketCap":88073945988},{"date":"2023-09-01","current":20.370742,"twenty":11.224626,"median":15.96462,"eighty":20.579258,"marketCap":87573820839},{"date":"2023-09-08","current":20.340426,"twenty":11.224626,"median":15.96462,"eighty":20.556869,"marketCap":87443491616},{"date":"2023-09-15","current":20.515915,"twenty":11.224626,"median":15.96462,"eighty":20.525527,"marketCap":88197917688},{"date":"2023-09-22","current":20.294089,"twenty":11.224626,"median":15.96462,"eighty":20.503675,"marketCap":87244289226},{"date":"2023-09-29","current":20.569892,"twenty":11.224626,"median":15.96462,"eighty":20.497429,"marketCap":88429967281},{"date":"2023-10-06","current":20.484859,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88064409704},{"date":"2023-10-13","current":20.66651,"twenty":11.224626,"median":15.96462,"eighty":20.47919,"marketCap":88845325455},{"date":"2023-10-20","current":19.930788,"twenty":11.224626,"median":15.96462,"eighty":20.469796,"marketCap":85682457723},{"date":"2023-10-27","current":19.520904,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":83920364243},{"date":"2023-11-03","current":21.737851,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":86757938711},{"date":"2023-11-10","current":21.323755,"twenty":11.217472,"median":15.933685,"eighty":20.408361,"marketCap":85105237415},{"date":"2023-11-17","current":21.224631,"twenty":11.217472,"median":15.933685,"eighty":20.421192,"marketCap":84709626635},{"date":"2023-11-24","current":21.271528,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":84896797327},{"date":"2023-12-01","current":21.951269,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":87609708889},{"date":"2023-12-08","current":22.627279,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":90307731873},{"date":"2023-12-15","current":23.341925,"twenty":11.219857,"median":15.940559,"eighty":20.455788,"marketCap":93159957984},{"date":"2023-12-22","current":22.432763,"twenty":11.217472,"median":15.933685,"eighty":20.452301,"marketCap":89531398889},{"date":"2023-12-29","current":23.493808,"twenty":11.215088,"median":15.919407,"eighty":20.445674,"marketCap":93766135792},{"date":"2024-01-05","current":24.305712,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97006528395},{"date":"2024-01-12","current":24.406967,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":97410646934},{"date":"2024-01-19","current":24.780811,"twenty":11.212541,"median":15.891644,"eighty":20.415603,"marketCap":98902695120},{"date":"2024-01-26","current":25.283622,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":100909462708},{"date":"2024-02-02","current":25.521038,"twenty":11.212703,"median":15.905129,"eighty":20.426781,"marketCap":101857014335},{"date":"2024-02-09","current":25.724697,"twenty":11.212703,"median":15.905129,"eighty":20.459114,"marketCap":101705162231},{"date":"2024-02-16","current":25.950297,"twenty":11.212703,"median":15.905129,"eighty":20.47919,"marketCap":102597095968},{"date":"2024-02-23","current":26.226454,"twenty":11.212703,"median":15.905129,"eighty":20.497429,"marketCap":103688908831},{"date":"2024-03-01","current":26.259071,"twenty":11.215088,"median":15.919407,"eighty":20.518368,"marketCap":103817863106},{"date":"2024-03-08","current":26.455316,"twenty":11.215088,"median":15.919407,"eighty":20.545637,"marketCap":104593737995},{"date":"2024-03-15","current":26.067447,"twenty":11.215088,"median":15.919407,"eighty":20.571273,"marketCap":103060256739},{"date":"2024-03-22","current":26.311258,"twenty":11.215088,"median":15.919407,"eighty":20.621194,"marketCap":104024189946},{"date":"2024-03-28","current":26.264779,"twenty":11.215088,"median":15.919407,"eighty":20.655603,"marketCap":103840430104},{"date":"2024-04-05","current":25.468926,"twenty":11.212703,"median":15.905129,"eighty":20.723691,"marketCap":100693945789},{"date":"2024-04-12","current":25.015007,"twenty":11.212703,"median":15.905129,"eighty":20.904157,"marketCap":98899332126},{"date":"2024-04-19","current":24.299337,"twenty":11.212703,"median":15.947434,"eighty":21.122307,"marketCap":96069860405},{"date":"2024-04-26","current":24.304801,"twenty":11.215088,"median":16.055559,"eighty":21.212036,"marketCap":96091459812},{"date":"2024-05-03","current":26.22078,"twenty":11.215088,"median":16.138956,"eighty":21.263447,"marketCap":101154526467},{"date":"2024-05-10","current":27.070653,"twenty":11.215088,"median":16.168653,"eighty":21.31672,"marketCap":104433166904},{"date":"2024-05-17","current":27.070094,"twenty":11.215088,"median":16.294592,"eighty":21.377367,"marketCap":104431009193},{"date":"2024-05-24","current":27.42218,"twenty":11.215088,"median":16.403186,"eighty":21.543145,"marketCap":105789287676},{"date":"2024-05-31","current":27.124068,"twenty":11.215088,"median":16.446392,"eighty":21.604318,"marketCap":104639228214},{"date":"2024-06-07","current":27.987644,"twenty":11.215088,"median":16.556015,"eighty":21.765364,"marketCap":107970732547},{"date":"2024-06-14","current":28.708036,"twenty":11.212703,"median":16.641161,"eighty":21.875339,"marketCap":110749863104},{"date":"2024-06-21","current":29.206942,"twenty":11.212541,"median":16.702347,"eighty":21.926914,"marketCap":112674540478},{"date":"2024-06-28","current":29.387879,"twenty":11.212055,"median":16.849661,"eighty":22.012139,"marketCap":113372559682},{"date":"2024-07-05","current":28.639241,"twenty":11.212055,"median":16.930926,"eighty":22.201171,"marketCap":110484464767},{"date":"2024-07-12","current":30.210346,"twenty":11.212055,"median":17.140309,"eighty":22.42349,"marketCap":116545472325},{"date":"2024-07-15","current":30.763504,"twenty":11.212055,"median":17.191109,"eighty":22.533173,"marketCap":118679447575},{"date":"2024-08-02","current":27.30119,"twenty":11.206899,"median":17.301169,"eighty":22.615128,"marketCap":117987551031},{"date":"2024-08-09","current":27.805935,"twenty":11.206899,"median":17.352971,"eighty":22.804619,"marketCap":120168907862},{"date":"2024-08-16","current":29.353886,"twenty":11.206899,"median":17.547174,"eighty":23.185349,"marketCap":126858689969},{"date":"2024-08-23","current":29.661828,"twenty":11.206899,"median":17.668241,"eighty":23.520288,"marketCap":128189522712},{"date":"2024-08-30","current":29.443796,"twenty":11.206899,"median":17.89624,"eighty":23.992786,"marketCap":127247254273},{"date":"2024-09-06","current":28.735255,"twenty":11.206899,"median":18.004331,"eighty":24.127024,"marketCap":124185151686},{"date":"2024-09-13","current":29.082408,"twenty":11.206899,"median":18.146003,"eighty":24.305165,"marketCap":125685441639},{"date":"2024-09-20","current":28.726014,"twenty":11.206899,"median":18.30367,"eighty":24.388542,"marketCap":124145215910},{"date":"2024-09-27","current":25.973018,"twenty":11.206899,"median":18.360535,"eighty":24.456418,"marketCap":112247592778},{"date":"2024-10-04","current":25.339402,"twenty":11.206899,"median":18.388792,"eighty":24.700046,"marketCap":109509293778},{"date":"2024-10-11","current":24.950541,"twenty":11.206899,"median":18.407637,"eighty":24.906035,"marketCap":107828753161},{"date":"2024-10-18","current":24.930811,"twenty":11.206899,"median":18.470866,"eighty":25.028446,"marketCap":107743484883},{"date":"2024-10-25","current":23.199293,"twenty":11.206899,"median":18.52949,"eighty":25.028446,"marketCap":100260383988},{"date":"2024-10-31","current":23.046696,"twenty":11.206899,"median":18.566384,"eighty":25.028446,"marketCap":99600904015},{"date":"2024-11-08","current":19.05799,"twenty":11.206442,"median":18.637362,"eighty":25.035165,"marketCap":88705416518},{"date":"2024-11-15","current":18.087847,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":84189883902},{"date":"2024-11-22","current":17.20924,"twenty":11.206442,"median":18.657932,"eighty":25.035165,"marketCap":80100405829},{"date":"2024-11-29","current":17.341458,"twenty":11.206442,"median":18.64179,"eighty":25.035165,"marketCap":80715817946},{"date":"2024-12-06","current":17.750134,"twenty":11.206442,"median":18.605435,"eighty":25.035165,"marketCap":82618000854},{"date":"2024-12-13","current":17.127643,"twenty":11.206442,"median":18.54394,"eighty":25.035165,"marketCap":79720614785},{"date":"2024-12-20","current":16.371315,"twenty":11.206442,"median":18.478932,"eighty":25.035165,"marketCap":76200285330},{"date":"2024-12-27","current":16.566176,"twenty":11.206442,"median":18.419158,"eighty":25.035165,"marketCap":77107265077},{"date":"2025-01-03","current":16.531734,"twenty":11.206442,"median":18.397243,"eighty":25.035165,"marketCap":76946956675},{"date":"2025-01-10","current":16.957053,"twenty":11.205984,"median":18.379244,"eighty":25.041885,"marketCap":78926604046},{"date":"2025-01-17","current":16.024125,"twenty":11.205984,"median":18.326784,"eighty":25.041885,"marketCap":74584290575},{"date":"2025-01-24","current":16.056718,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":74735991813},{"date":"2025-01-31","current":15.789506,"twenty":11.205984,"median":18.268644,"eighty":25.041885,"marketCap":73492256835},{"date":"2025-02-07","current":17.513328,"twenty":11.205984,"median":18.205402,"eighty":25.041885,"marketCap":77279312131},{"date":"2025-02-14","current":16.353971,"twenty":11.205984,"median":18.068539,"eighty":25.041885,"marketCap":72163532332},{"date":"2025-02-21","current":16.881503,"twenty":11.205984,"median":17.989927,"eighty":25.041885,"marketCap":74491319165},{"date":"2025-02-28","current":17.045462,"twenty":11.205984,"median":17.861315,"eighty":25.041885,"marketCap":75214806015},{"date":"2025-03-07","current":16.940198,"twenty":11.205526,"median":17.547284,"eighty":24.953276,"marketCap":74750318896},{"date":"2025-03-14","current":16.507743,"twenty":11.205526,"median":17.434844,"eighty":24.953276,"marketCap":72842068816},{"date":"2025-03-21","current":16.071408,"twenty":11.205526,"median":17.347954,"eighty":24.876365,"marketCap":70916694786},{"date":"2025-03-28","current":15.421634,"twenty":11.205526,"median":17.320865,"eighty":24.876365,"marketCap":68049503556},{"date":"2025-04-04","current":14.810668,"twenty":11.205526,"median":17.220578,"eighty":24.757629,"marketCap":65353551816},{"date":"2025-04-11","current":13.252327,"twenty":11.205984,"median":17.191443,"eighty":24.571362,"marketCap":58477215997},{"date":"2025-04-17","current":13.322422,"twenty":11.205984,"median":17.137002,"eighty":24.420237,"marketCap":58786517328},{"date":"2025-04-25","current":14.54678,"twenty":11.205526,"median":16.999149,"eighty":24.304801,"marketCap":64189123276},{"date":"2025-05-02","current":13.856076,"twenty":11.205526,"median":16.947475,"eighty":24.14557,"marketCap":62342643230},{"date":"2025-05-09","current":12.861961,"twenty":11.205526,"median":16.904119,"eighty":24.034457,"marketCap":57869822741},{"date":"2025-05-16","current":13.738417,"twenty":11.205526,"median":16.818894,"eighty":23.30219,"marketCap":61813259090},{"date":"2025-05-23","current":14.016947,"twenty":11.205526,"median":16.720573,"eighty":23.015778,"marketCap":63066451884},{"date":"2025-05-30","current":14.217508,"twenty":11.205526,"median":16.67877,"eighty":22.627279,"marketCap":63968835228},{"date":"2025-06-06","current":11.344838,"twenty":11.205526,"median":16.611067,"eighty":22.386399,"marketCap":51043831635}],"updateTime":1749377147004}}}